Table.

Power of study by Rajput et al.[1]

	Reduction (%) in number of Purkinje cells in ET cases vs. controls (Rajput et al.[1])	Sample size used by Rajput et al.[1]	Power to detect a 20% reduction in number of Purkinje cells in ET cases vs. controls	Sample size needed for adequate power to detect a 20% reduction in Purkinje cells in ET
Purkinje cell count 1 (sectioned Through any part of nucleolus)	23.7%	7 (ET) vs. 2 (controls)	15.2%	7 (ET) vs. 17 (controls)
Purkinje cell count 2 (sectioned Through any part of nucleus	11.3%	7 vs. 2	17.6%	7 vs. 15
Purkinje cell count 3 (sectioned Through any part of cell body)	5.8%	7 vs. 2	13.7%	7 vs. 19
	Reduction (%) in number of Purkinje cells in ET cases vs. PD cases (Rajput et al.[1])	Sample size used by Rajput et al.[1]	Power to detect a 20% reduction in number of Purkinje cells in ET cases vs. PD cases	Sample size needed for adequate power to detect a 20% reduction in Purkinje cells in ET
Purkinje cell count 1 (sectioned Through any part of nucleolus)	0.0%	7 (ET) vs. 6 (PD)	35.1%	7 (ET) vs. 17(PD)
Purkinje cell count 2 (sectioned Through any part of nucleus	31.4%	7 vs. 6	41.2%	7 vs. 15
Purkinje cell count 3 (sectioned Through any part of cell body)	9.3%	7 vs. 6	31.2%	7 vs. 19